Across TCGA pan-cancer cohorts, RPL14P5 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL14P5’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL14P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL14P5 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

COAD, LIHC, and THCA are the cancer types where RPL14P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL14P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.191	.005	5	view →
LIHC	All	II,III,IV	+0.036	.012	4	view →
THCA	All	II,III,IV	+0.063	.016	2	view →
PRAD	All	All	+0.041	.044	2	view →
KIRC	All	IV	−0.028	.032	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RPL14P5 RNA expression & survival · all RPL14P5 data types